Sun Pharmaceutical Industries

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue5,2035,1515,7584,5815,214
Expenses4,2964,3294,3564,3234,318
EBITDA1,4931,4362,012843.811,425
EBIT1,100966.391,619474.001,139
Profit Before Tax906.52751.471,402257.92895.64
Net Profit888.63721.31867.60237.82863.29
Financial Ratios
Operating Profit Margin29.74%27.86%36.34%19.14%27.81%
Net Profit Margin17.70%16.08%15.67%5.39%16.85%
Earning Per Share (Diluted)3.703.003.601.003.60
Dividends Per Share0.008.500.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ